Nucleic acid-controlled catalytic rnas for trigger-responsive regulation
US-2024425855-A1 · Dec 26, 2024 · US
US2025084414A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025084414-A1 |
| Application number | US-202318845379-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 6, 2023 |
| Priority date | Mar 9, 2022 |
| Publication date | Mar 13, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to fluorinated amphiphilic dendrimer structures (FJDs) capable of self-assembling into supramolecular systems of different size and shape. A further object is a supramolecular complex comprising at least one of the dendrimer structures according to the present invention and the use thereof in gene therapy.
Opening claim text (preview).
1 . Fluorinated dendrimeric structure of Formula (I) Wherein n is an integer between 1 and 5; R is selected from R 1 is selected from X is selected independently from: OH; (6) COOH (7) NH 2 (8) NH 3 + Y − (9) NR 2 2 (10) NR 2 3 + Y − (11) Wherein R 2 is selected independently from —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —CH(CH 3 ) 2 , —CH 2 OH, —CH 2 CH 2 OH; Y − is selected from: 2 . The structure according to claim 1 , wherein n is 2 or 3. 3 . The structure according to claim 1 , wherein R is 4 . The structure according to claim 1 , wherein R 1 is 5 . The structure according to claim 1 , wherein X=NH 3+ Y − and Y is selected from 6 . 6 . The structure according to claim 1 , wherein n=3, R is (2), R1 is (5), X=NH 3 + Y − , Y is (12) and it is FDG 2 N. 7 . A supramolecular complex comprising at least one of the dendrimeric structures according to claim 1 and one or more nucleic acids. 8 . The complex according to claim 7 , wherein the ratio between the nitrogen atoms of said dendrimeric structure and the phosphorus atoms of said one or more nucleic acids (N/P) is comprised between 5 and 40. 9 . The complex according to claim 7 , wherein N/P=30. 10 . A supramolecular complex according to claim 7 , for use in gene therapy.
Special delivery means, e.g. tissue-specific · CPC title
Conjugate · CPC title
MicroRNAs, miRNAs · CPC title
Dendritic macromolecules · CPC title
characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.